Neurochemistry

Will CMMC 2.0 Certification Be Mandatory in May 2023? Drip7 Provides Insight

Retrieved on: 
Tuesday, May 2, 2023
NIST, SPRS, Interview, Neurochemistry, CMMC, United States Department of Defense, Vestal, DIB, Certification, News, Level 1, Risk management, Medical device

SPOKANE, Wash., May 2, 2023 /PRNewswire-PRWeb/ -- With the original May 2023 rollout date here, and no official word on when CMMC 2.0 will appear in contracts, speculations have been raging. Some anticipate as soon as June of this year to spring of 2024, but as of yet, no one knows. But does it even matter when it shows up?

Key Points: 
  • SPOKANE, Wash., May 2, 2023 /PRNewswire-PRWeb/ -- With the original May 2023 rollout date here, and no official word on when CMMC 2.0 will appear in contracts, speculations have been raging.
  • Some anticipate as soon as June of this year to spring of 2024, but as of yet, no one knows.
  • According to Noël Vestal, the Compliance Officer at PreVeil, "The most important thing I keep telling everyone is that CMMC is just a certification, NIST 800-171 is the actual compliance framework.
  • Training is always a key element to staying secure — whether you're seeking CMMC certification or not.

Thesis, the First High Quality and Customized Nootropics Solution, Raises Total of $13.5 Million in Funding

Retrieved on: 
Tuesday, May 2, 2023
Finance, Health, Mental Health, Professional Services, Vitamins, Supplements, Philanthropy, Fitness & Nutrition, Fund Raising, Cognition, Neurochemistry, Trust, Multimedia, NBA, Kate Bock, MBX, Cryptocurrency, Fashion design, Thesis

Previously the company raised $5.1 million in an undisclosed seed round that included Unilever Ventures, MBX, Trust Ventures and Redo Ventures.

Key Points: 
  • Previously the company raised $5.1 million in an undisclosed seed round that included Unilever Ventures, MBX, Trust Ventures and Redo Ventures.
  • View the full release here: https://www.businesswire.com/news/home/20230502005870/en/
    Thesis recognizes that nootropics are not a one-size-fits-all wellness category.
  • Through the highest quality ingredients and a customized approach, the brand helps people effectively boost their cognition & productivity.
  • The new capital will support Thesis as it makes key executive hires, expands out its product selection and undergoes clinical trials.

Mindpath Health releases its 7 Misconceptions About Mental Health

Retrieved on: 
Tuesday, April 18, 2023
Ankle, Substance dependence, Violence, Religion, Education, Homelessness, Genetics, Face, Suicide, MD, Disability, Anxiety, Workplace, Law enforcement, Neurochemistry, COVID-19, Eye, Cancer, DSM-IV codes, Multimedia, Personality, Mental, Depression, Abuse, Love, Child, Health, Injury, Trauma, Mental health, Nursing

DENVER, April 18, 2023 /PRNewswire/ -- Mental health care has come a long way in being integrated into health and wellness plans.

Key Points: 
  • DENVER, April 18, 2023 /PRNewswire/ -- Mental health care has come a long way in being integrated into health and wellness plans.
  • Depression and anxiety rates increased dramatically across the world during the COVID-19 pandemic, and mental health was considered just as important as physical health.
  • Here are some of the biggest misconceptions people have about mental health:
    Sometimes, admitting we need help with a mental health issue can feel like we're admitting a horrible secret.
  • Raising awareness about good mental health care is essential to accepting ourselves and others and the challenges we face.

Is there a programming language for the brain? Dandelion Science Corp and the Swiss Federal Institute of Technology (EPFL) announce brain research collaboration.

Retrieved on: 
Tuesday, February 28, 2023
Merck, Taraxacum, Neurochemistry, Psychiatry, Drug development, EPFL, Partnership, Brain, Research, Publication, Neurology, Google Images, Dimitri Van De Ville, Science, DSM-IV codes, Novartis, Language, Health, Medical imaging, Biogen

NEW YORK, Feb. 28, 2023 /PRNewswire/ -- Dandelion Science Corp, a US-Swiss neurotechnology company, is excited to announce a new neuroscience research collaboration with Professor Dimitri Van De Ville at EPFL in Switzerland. This collaboration will advance Dandelion's technology platform with the latest in neuroimaging systems.

Key Points: 
  • NEW YORK, Feb. 28, 2023 /PRNewswire/ -- Dandelion Science Corp, a US-Swiss neurotechnology company, is excited to announce a new neuroscience research collaboration with Professor Dimitri Van De Ville at EPFL in Switzerland.
  • At Dandelion, we are developing a platform to program network dynamics in the brain.
  • "With this partnership, we will combine state-of-the-art imaging technology with the latest neuroscientific insights to probe brain function and dysfunction.
  • "Technology is starting to offer solutions to neuroscience research that a few years ago were out of our reach.

Jovive Health Launches New Medication-Assisted Treatment Services

Retrieved on: 
Monday, February 13, 2023
DO, American Society of Addiction Medicine, MAT, Drug, Neurochemistry, OUD, Buprenorphine, Medicine, Patient, Substance abuse, FDA, Society, Opioid, Addiction medicine, Nursing, Pharmaceutical industry

MAT with buprenorphine decreases the physical symptoms of opioid withdrawals and cravings, enabling patients to safely stop using opioids.

Key Points: 
  • MAT with buprenorphine decreases the physical symptoms of opioid withdrawals and cravings, enabling patients to safely stop using opioids.
  • Jovive Health clinics offer convenient access to comprehensive primary and urgent care services with extended hours and telehealth appointments.
  • New patients enroll in a multi-appointment MAT program that is designed to stabilize symptoms and develop an individualized treatment plan.
  • Treatment may be covered by a health plan but is also available at a reasonable out-of-pocket cost.

CABRI Awards $40,000 in Fellowships to Ten Undergraduate Researchers

Retrieved on: 
Thursday, December 15, 2022
Laboratory, Biotechnology, SNUC, Organic acid, Cayman Chemical Company, Endocrinology, Research, Neurochemistry, Atherosclerosis, Crystallization, Student, B-cell lymphoma, Fine chemical, Pharmaceutical industry, Neratovice

ANN ARBOR, Mich., Dec. 15, 2022 /PRNewswire-PRWeb/ -- Cayman joins the Cayman Biomedical Research Institute (CABRI) in recognizing the ten undergraduate students who have been awarded fellowships by CABRI for the 2022-2023 academic year. The fellowship awards are given to talented undergraduates that are pursuing a research project of their own under the guidance of a faculty mentor.

Key Points: 
  • Our scientists are experts in the synthesis, purification, and characterization ofbiochemicalsranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others for use as research reagents and qualified standards.
  • We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
  • In addition,Cayman Contract Servicesprovides discovery and preclinical development services to the global pharmaceutical, biotechnology, and academic research markets.
  • CABRI also provides scholarships to college-bound students who have lost a parent to SNUC (sinonasal undifferentiated carcinoma) or B cell lymphoma.

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson's Disease Treatment

Retrieved on: 
Wednesday, October 12, 2022
SAN, CA, Cannabis, Drug Quality and Security Act, Disease, GPR55, Meritorious Autonomous University of Puebla, Medical cannabis, Neuropharmacology, Criticism of the Food and Drug Administration, Neuroscience, Parkinson's disease, The O.C., Autonomous university, Central nervous system, Securities Act of 1933, Neurochemistry, Autonomous University of Barcelona, Food, Mouse, Health, CEO, Safe harbor, Nature, Securities Exchange Act of 1934, Safety, OTC, GLOBE, DRUG, Frontiers Media, FDA, CNBC, Medical Marijuana, Inc., Drug, Medical device, CBD, Pharmacology

"In our model, we studied the effect of CBD administered to mice that were in a parkinsonian state.

Key Points: 
  • "In our model, we studied the effect of CBD administered to mice that were in a parkinsonian state.
  • To ensure the most scientifically reliable, valid, and trustworthy results, HempMeds provided its flagship RSHO-X 5,000 to aid in the studys execution.
  • "Our commitment is to provide free access to non-psychoactive cannabis and its benefits, said Raul Elizalde, CEO of HempMeds.
  • Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

Scientists Create Non-Psychedelic Compound with Same Anti-depressant Effect

Retrieved on: 
Wednesday, September 28, 2022
Mental Health, Research, Other Natural Resources, Other Health, Alternative Medicine, Health, Other Science, Science, Natural Resources, Tao, Selective serotonin reuptake inhibitor, National, Depression, Human, THP, LSD, DARPA, Patient, UNC, 5-HT2A, R-69, Anxiety, Research, Hallucination, Psychiatry, Eugene Higgins, Mouse, Serotonin, Doctor of Philosophy, DMT, Â, UCSF, Duke, Ketamine, Michael Hooker, FDA, MD, UNC School of Medicine, University of North Carolina at Chapel Hill, Stanford University, AstraZeneca, Permeability, Tony Hawk's Pro Skater 1 + 2, Department, Mount Sinai, Brain, Zehnder Confair, Psilocybin, Esketamine, Ellman, Neurochemistry, Defense, University of California, San Francisco, Protein, Cell, N,N-Dimethyltryptamine, Substance abuse, SSRI, Department of Defense Office of Inspector General, Multimedia, Neuron, Pharmaceutical industry, Yale University, Medicine, Pharmacology, Chemistry, Nature

Some advocates and scientists believe the actual psychedelic trip hallucinations and profound emotional experiences is what leads to long-lasting therapeutic effects.

Key Points: 
  • Some advocates and scientists believe the actual psychedelic trip hallucinations and profound emotional experiences is what leads to long-lasting therapeutic effects.
  • Other scientists speculate that if the trip could be eliminated from such drugs, then only the therapeutic effects might remain.
  • We were basically running a chemistry experiment to see if we could create a compound to activate 5-HT2A.
  • It would be a game changer to create a one-dose, long-acting therapy to help people with treatment-resistant depression and other conditions.

When Antibiotics Fail, Lifestyle Healing Institute Provides Holistic Chronic Lyme Treatment

Retrieved on: 
Monday, September 19, 2022
Time, Infection, Degenerative disease, Lyme disease, Center, IV, Diet, Nursing, Brain, Tick, Hormone, Psychotherapy, Conditional sentence, Health, Migraine, Acupuncture, Genetically modified bacteria, Survival, Patient, Diabetes, Neurochemistry, Exercise, LHI, Yoga, Arthralgia, Chronic Lyme disease, Korea Disease Control and Prevention Agency, GLOBE, Occupational therapy, Fatigue, Disease, Chronic pain, Vaccine, Pharmaceutical industry, Medical imaging, Healthcare

Most recover quickly, but some are left with symptoms far after the initial infection, according to Lifestyle Healing Institute (LHI) , an alternative treatment center specializing in natural Lyme treatment.

Key Points: 
  • Most recover quickly, but some are left with symptoms far after the initial infection, according to Lifestyle Healing Institute (LHI) , an alternative treatment center specializing in natural Lyme treatment.
  • And even one-third (34%) of people treated successfully will develop long-term symptoms known as Post-Treatment Lyme Disease Syndrome, commonly called chronic Lyme disease.
  • Currently, other than symptom management and antibiotics, there are not a lot of standards of care for chronic Lyme disease.
  • Lifestyle Healing Institute is a complementary and alternative treatment center specializing in chronic illness and over-prescribed medications.

Discovery Behavioral Health Appoints David Semanco as Program Director for New Life Treatment Center in Maryland

Retrieved on: 
Wednesday, June 29, 2022
Samanco District, DBH, Patient, Addiction medicine, Psychiatry, CEO, Drug, Mental health service, Hospital, Substance abuse, Association, Berklee College of Music, Alternative, Health, Apple, Awareness, Master's degree, Eating disorder, Perception, Technology, Music therapy, Neurochemistry, MAT, Human services, Lists of diseases, New Life, TMS, Information technology, Neurofeedback, Mental health, Happiness, Program, Pharmaceutical industry, Medicine, Discovery, Music, Addiction

LOS ANGELES, June 29, 2022 /PRNewswire/ -- Discovery Behavioral Health, Inc ., an expanding network of evidence-based mental health, substance use and eating disorder treatment centers, has appointed David Semanco as Program Director of New Life Addiction Counseling & Mental Health Services inPasadena, Maryland, just outside of Annapolis.

Key Points: 
  • LOS ANGELES, June 29, 2022 /PRNewswire/ -- Discovery Behavioral Health, Inc ., an expanding network of evidence-based mental health, substance use and eating disorder treatment centers, has appointed David Semanco as Program Director of New Life Addiction Counseling & Mental Health Services inPasadena, Maryland, just outside of Annapolis.
  • Semanco is a Master Addiction Counselor specializing in the application of complementary therapies to enhance the addiction treatment and recovery process.
  • He transitioned into the addiction treatment field in 2002 following successful careers in information technology and music.
  • He continues to incorporate technology and music into clinical practice as evidenced by his work with neurofeedback and music therapy.